• $68.5M
    Market Cap
  • 35.34%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
-100,000
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
+100.00%
-100,000
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-60.0M
-6.25%
-64.0M
+39.04%
-46.0M
N/A
0
N/A
Depreciation and Amortization Expense
1.4M
+34.79%
1.0M
+87.69%
536,000
+47.25%
364,000
N/A
Total Operating Expenses
84.1M
-5.70%
89.2M
+32.93%
67.1M
+105.48%
32.7M
N/A
Operating Profit
-84.1M
-5.70%
-89.2M
+32.93%
-67.1M
+105.48%
-32.7M
N/A
Interest Income
N/A
N/A
N/A
N/A
7.0M
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
-100.00%
7.0M
N/A
0
N/A
Total Nonoperating Income and Expense
6.2M
-28.16%
8.6M
+28.71%
6.7M
+350.67%
1.5M
N/A
Income before Taxes
-84.1M
-5.70%
-89.2M
+32.93%
-67.1M
+105.48%
-32.7M
N/A
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-77.9M
-3.29%
-80.6M
+33.40%
-60.4M
+93.76%
-31.2M
N/A
Net Income from Continuing Operations Applicable to Common
-77.9M
-3.29%
-80.6M
+33.40%
-60.4M
+93.76%
-31.2M
N/A
Basic EPS and Net Income
-2.02
-15.13%
-2.38
-13.14%
-2.74
-63.76%
-7.56
N/A
Diluted EPS and Net Income
-2.02
-15.13%
-2.38
-13.14%
-2.74
-63.76%
-7.56
N/A
Basic Weighted Average Shares
38.5M
+13.96%
33.8M
+53.06%
22.1M
+435.63%
4.1M
N/A
Diluted Weighted Average Shares
38.5M
+13.96%
33.8M
+53.06%
22.1M
+435.63%
4.1M
N/A
Balance Sheet
Cash and Cash Equivalents
41.5M
+4.22%
39.8M
+10.56%
36.0M
+22.01%
29.5M
N/A
Short-Term Investments
77.1M
-44.81%
139.7M
+52.73%
91.4M
-6.91%
98.2M
N/A
Cash and Cash Equivalents and Short-Term Investments
118.6M
-33.93%
179.5M
+40.82%
127.5M
-0.23%
127.8M
N/A
Total Current Assets
120.4M
-33.69%
181.6M
+40.05%
129.7M
-1.82%
132.1M
N/A
Accumulated Depreciation
3.3M
+69.11%
2.0M
+105.23%
956,000
+127.62%
420,000
N/A
Property and Plant and Equipment and Net
4.9M
+9.35%
4.5M
+28.51%
3.5M
+66.30%
2.1M
N/A
Total Long-Term Assets
1.7M
+0.36%
1.6M
-55.84%
3.7M
+78.30%
2.1M
N/A
Total Assets
129.7M
-34.02%
196.6M
+42.18%
138.3M
-23.71%
181.2M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
15.7M
-9.00%
17.2M
+29.40%
13.3M
+104.16%
6.5M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.5M
-40.61%
2.6M
-35.59%
4.0M
-5.12%
4.2M
N/A
Total Liabilities
17.2M
-13.14%
19.8M
+16.00%
17.1M
+58.78%
10.8M
N/A
Retained Earnings
-274.9M
+39.55%
-197.0M
+69.19%
-116.4M
+107.77%
-56.0M
N/A
Total Stockholders Equity
112.5M
-36.35%
176.8M
+45.87%
121.2M
-28.91%
170.5M
N/A
Total Shares Outstanding
31.6M
+1.34%
31.2M
+38.67%
22.5M
+2.75%
21.9M
N/A
Cash Flow
Cash from Operating Activities
-63.7M
-3.05%
-65.7M
+54.00%
-42.6M
+41.58%
-30.1M
N/A
Capital Expenditures
1.7M
-39.70%
2.8M
+114.91%
1.3M
-40.54%
2.2M
N/A
Cash from Investing Activities
66.1M
+227.68%
-51.8M
-202.08%
50.7M
+135.80%
-141.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-749,000
-100.62%
121.0M
+7,888.10%
-1.6M
-101.53%
101.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
67,103.00%
N/A
N/A
N/A
Return on Assets
-47.75%
-0.76%
-48.11%
+27.28%
-37.80%
N/A
N/A
N/A
Return on Equity
-53.86%
-0.39%
-54.07%
+30.57%
-41.41%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
7.69
-27.12%
10.55
+8.23%
9.75
N/A
N/A
N/A
Cash Ratio
2.65
+14.53%
2.31
-14.56%
2.71
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow